"Heptanoic Acids" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
7-carbon saturated monocarboxylic acids.
| Descriptor ID |
D006538
|
| MeSH Number(s) |
D10.251.450
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Heptanoic Acids".
Below are MeSH descriptors whose meaning is more specific than "Heptanoic Acids".
This graph shows the total number of publications written about "Heptanoic Acids" by people in this website by year, and whether "Heptanoic Acids" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 1 | 0 | 1 |
| 1996 | 2 | 0 | 2 |
| 1997 | 2 | 0 | 2 |
| 1998 | 1 | 0 | 1 |
| 2000 | 2 | 0 | 2 |
| 2001 | 3 | 1 | 4 |
| 2002 | 1 | 0 | 1 |
| 2003 | 5 | 0 | 5 |
| 2004 | 1 | 0 | 1 |
| 2005 | 4 | 3 | 7 |
| 2006 | 2 | 1 | 3 |
| 2007 | 4 | 1 | 5 |
| 2008 | 9 | 3 | 12 |
| 2009 | 4 | 1 | 5 |
| 2010 | 0 | 3 | 3 |
| 2011 | 3 | 0 | 3 |
| 2012 | 4 | 1 | 5 |
| 2013 | 1 | 1 | 2 |
| 2014 | 2 | 2 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Heptanoic Acids" by people in Profiles.
-
Coronary artery calcium score. JAMA. 2014 Aug 27; 312(8):837-8.
-
Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial. Stroke. 2014 Oct; 45(10):2974-82.
-
Effect of alirocumab, a monoclonal proprotein convertase subtilisin/kexin 9 antibody, on lipoprotein(a) concentrations (a pooled analysis of 150 mg every two weeks dosing from phase 2 trials). Am J Cardiol. 2014 Sep 01; 114(5):711-5.
-
Effects of fenofibric acid on carotid intima-media thickness in patients with mixed dyslipidemia on atorvastatin therapy: randomized, placebo-controlled study (FIRST). Arterioscler Thromb Vasc Biol. 2014 Jun; 34(6):1298-306.
-
A 52-week placebo-controlled trial of evolocumab in hyperlipidemia. N Engl J Med. 2014 May 08; 370(19):1809-19.
-
Prediction of major vascular events after stroke: the stroke prevention by aggressive reduction in cholesterol levels trial. J Stroke Cerebrovasc Dis. 2014 Apr; 23(4):778-84.
-
Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation. Arterioscler Thromb Vasc Biol. 2013 Jul; 33(7):1591-600.
-
Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein. Ann Rheum Dis. 2014 Mar; 73(3):557-66.
-
Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia. N Engl J Med. 2012 Nov 15; 367(20):1891-900.
-
Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia with residual risk in addition to atorvastatin therapy (FIRST) trial. Cardiovasc Drugs Ther. 2012 Aug; 26(4):349-58.